Dữ liệu Xếp hạng Học thuật WoS SCIE & CAS
Bảng Xếp hạng Tạp chí Khoa học Toàn cầu
Khám phá thứ bậc học thuật, đối chiếu chỉ số Clarivate Impact Factor, phân hạng Web of Science Q1–Q4 và phân vùng CAS.
Hiển thị 26–50 của 232 tạp chí khoa học quốc tế (Oncology)
| Hạng | Tên Tạp chí & Mã ISSN | Impact Factor | H-Index | Phân hạng WoS | Scopus SJR | Phân vùng CAS | Tự trích dẫn | Số bài/năm | Nhà xuất bản |
|---|---|---|---|---|---|---|---|---|---|
| #26 | npj Precision Oncology ISSN: 2397-768XTop Tier | 9.9 | 59 | Q1 | 3.616Q1 | CAS Tier 1 | 2.9% | 99 | Springer Nature |
| #27 | Cancer Immunology Research ISSN: 2326-6066 / 2326-6074Top Tier | 7.9 | 157 | Q1 | 3.48Q1 | CAS Tier 1 | 2.5% | 111 | American Association for Cancer Research Inc. |
| #28 | European Journal of Cancer ISSN: 0959-8049 / 1879-0852Top Tier | 7.9 | 263 | Q1 | 2.692Q1 | CAS Tier 1 | 2.6% | 436 | Elsevier Ltd |
| #29 | British Journal of Cancer ISSN: 0007-0920 / 1532-1827Top Tier | 7.8 | 290 | Q1 | 2.803Q1 | CAS Tier 1 | 1.6% | 376 | Springer Nature |
| #30 | Jnci-Journal of the National Cancer Institute ISSN: 0027-8874 / 1460-2105Top Tier | 7.7 | 403 | Q1 | 3.786Q1 | CAS Tier 1 | 3% | 198 | Oxford University Press |
| #31 | International Journal of Oncology ISSN: 1019-6439 / 1791-2423 | 7.3 | 146 | Q1 | 1.408Q1 | CAS Tier 2 | 0% | 124 | Spandidos Publications |
| #32 | Cancer Cell International ISSN: 1475-2867Top Tier | 7 | 100 | Q1 | 1.75Q1 | CAS Tier 2 | 0% | 670 | BioMed Central |
| #33 | Molecular Cancer Therapeutics ISSN: 1535-7163 / 1538-8514Top Tier | 6.9 | 212 | Q1 | 2.392Q1 | CAS Tier 2 | 0% | 230 | American Association for Cancer Research Inc. |
| #34 | Seminars in Oncology ISSN: 0093-7754 / 1532-8708Top Tier | 6.8 | 153 | Q1 | 1.536Q1 | CAS Tier 4 | 3.3% | 33 | W.B. Saunders Ltd |
| #35 | Chinese Journal of Cancer Research ISSN: 1000-9604 / 1993-0631 | 6.7 | 51 | Q1 | 1.406Q1 | CAS Tier 1 | 14.3% | 62 | Springer Berlin Heidelberg |
| #36 | Breast Cancer Research ISSN: 1465-5411 / 1465-542X | 6.2 | 186 | Q1 | 1.907Q1 | CAS Tier 2 | 1.6% | 108 | BioMed Central |
| #37 | Oncoimmunology ISSN: 2162-4011 / 2162-402XTop Tier | 6.2 | 134 | Q1 | 2.438Q1 | CAS Tier 2 | 3.1% | 218 | Landes Bioscience |
| #38 | Oncogenesis ISSN: 2157-9024 | 6 | 78 | Q1 | 2.081Q1 | CAS Tier 2 | 1.7% | 78 | Springer Nature |
| #39 | Current Treatment Options in Oncology ISSN: 1527-2729 / 1534-6277Top Tier | 5.8 | 77 | Q1 | 1.626Q1 | CAS Tier 2 | 0% | 114 | Springer US |
| #40 | Cancer Biology & Therapy ISSN: 1538-4047 / 1555-8576 | 5.7 | 138 | Q1 | 1.407Q1 | CAS Tier 2 | 0% | 51 | Landes Bioscience |
| #41 | Clinical Epigenetics ISSN: 1868-7083 / 1868-7075Top Tier | 5.7 | 94 | Q1 | 1.787Q1 | CAS Tier 2 | 4.2% | 208 | BioMed Central |
| #42 | Cancer ISSN: 0008-543X / 1097-0142Top Tier | 5.6 | 359 | Q1 | 2.427Q1 | CAS Tier 2 | 1.6% | 435 | John Wiley and Sons Inc. |
| #43 | Jco Oncology Practice ISSN: 2688-1527 / 2688-1535 | 5.5 | 91 | Q1 | 1.985Q1 | CAS Tier 2 | 6.4% | 227 | LIPPINCOTT WILLIAMS & WILKINS |
| #44 | Current Oncology Reports ISSN: 1523-3790 / 1534-6269Top Tier | 5.2 | 91 | Q1 | 1.595Q1 | CAS Tier 2 | 0% | 139 | Springer US |
| #45 | Targeted Oncology ISSN: 1776-2596 / 1776-260X | 5.1 | 65 | Q1 | 1.435Q1 | CAS Tier 2 | 2.3% | 67 | Springer International Publishing |
| #46 | Journal of Liquid Biopsy ISSN: 2950-1954 | 5 | 9 | Q2 | 0.832Q2 | — | N/A | — | ELSEVIER |
| #47 | Cancer Science ISSN: 1347-9032 / 1349-7006Top Tier | 4.9 | 178 | Q2 | 1.509Q1 | CAS Tier 2 | 2.2% | 426 | Wiley-Blackwell |
| #48 | International Journal of Cancer ISSN: 0020-7136 / 1097-0215Top Tier | 4.9 | 275 | Q2 | 1.901Q1 | CAS Tier 2 | 1.8% | 370 | Wiley-Liss Inc. |
| #49 | Cancer Imaging ISSN: 1470-7330 | 4.8 | 73 | Q2 | 1.16Q1 | CAS Tier 2 | 2.9% | 66 | BioMed Central |
| #50 | Cancers ISSN: 2072-6694 | 4.8 | 182 | Q2 | 1.41Q1 | CAS Tier 2 | 11.1% | 6,092 | MDPI (Basel, Switzerland) |